Health and Healthcare
Major Pharma Short Interest Faces Significant Drop
Published:
Last Updated:
The short interest data have been released for the August 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be big upside.
Drug prices may be under pressure due to the campaign rhetoric and under scrutiny, but if generic drugs are going to keep increasing in market share of existing drugs, then there would seem to be a reason for owning major pharmaceuticals.
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
Pfizer Inc. (NYSE: PFE) saw its short interest decrease to 39.63 million shares from the previous 47.81 million. Shares of Pfizer closed Wednesday at $34.82, within a 52-week trading range of $28.25 to $37.39.
Merck & Co. Inc. (NYSE: MRK) had a rise in short interest to 31.29 million shares, from 28.37 million in the previous period. Its shares closed Wednesday at $62.73, in a 52-week range of $47.97 to $64.00.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) short interest decreased to 13.80 million shares. The previous level was 20.81 million. Shares closed Wednesday at $51.63, in a 52-week range of $48.01 to $66.55.
Bristol-Myers Squibb Co. (NYSE: BMY) saw its short interest decrease to 9.65 million shares from the previous reading of 14.06 million. Shares closed Wednesday at $58.59, within a 52-week range of $56.32 to $77.12.
AbbVie Inc. (NYSE: ABBV) short interest fell to 48.00 million shares, compared to the previous 50.88 million. Shares of AbbVie closed Wednesday at $65.06, in a 52-week trading range of $45.45 to $68.12.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
